{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:42:35Z","timestamp":1791247355864,"version":"4.1.0"},"reference-count":34,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>c-Maf translocation or overexpression has been observed in human multiple myeloma. Although c-maf might function as an oncogene in multiple myeloma, a role for this gene in other cancers has not been shown. In this study, we have found that mice transgenic for c-Maf whose expression was direct to the T-cell compartment developed T-cell lymphoma. Moreover, we showed that cyclin D2, integrin \u03b27, and ARK5 were up-regulated in c-Maf transgenic lymphoma cells. Furthermore, 60% of human T-cell lymphomas (11 of 18 cases), classified as angioimmunoblastic T-cell lymphoma, were found to express c-Maf. These results suggest that c-Maf might cause a type of T-cell lymphoma in both mice and humans and that ARK5, in addition to cyclin D2 and integrin \u03b27, might be downstream target genes of c-Maf leading to malignant transformation. (Cancer Res 2006; 66(2): 812-9)<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-2154","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T20:04:17Z","timestamp":1137701057000},"page":"812-819","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Overexpression of c-Maf Contributes to T-Cell Lymphoma in Both Mice and Human"],"prefix":"10.1158","volume":"66","author":[{"given":"Naoki","family":"Morito","sequence":"first","affiliation":[{"name":"1Department of Anatomy and Embryology, Biomolecular and Integrated Medical Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigyou","family":"Yoh","sequence":"additional","affiliation":[{"name":"2Pathophysiology of Renal Diseases, Medical Sciences for Control of Pathological Processes,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Fujioka","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Embryology, Biomolecular and Integrated Medical Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Nakano","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Embryology, Biomolecular and Integrated Medical Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homare","family":"Shimohata","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Embryology, Biomolecular and Integrated Medical Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Embryology, Biomolecular and Integrated Medical Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Yamada","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Embryology, Biomolecular and Integrated Medical Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Maeda","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Embryology, Biomolecular and Integrated Medical Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Matsuno","sequence":"additional","affiliation":[{"name":"5Department of Internal Medicine II, Kumamoto University School of Medicine, Kumamoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hata","sequence":"additional","affiliation":[{"name":"5Department of Internal Medicine II, Kumamoto University School of Medicine, Kumamoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"6Cancer Physiology Project, National Cancer Center Research Institute East, Chiba, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehiko","family":"Imagawa","sequence":"additional","affiliation":[{"name":"3Clinical and Experimental Hematology, Major of Advanced Biomedical Applications,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mitsuya","sequence":"additional","affiliation":[{"name":"5Department of Internal Medicine II, Kumamoto University School of Medicine, Kumamoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Esumi","sequence":"additional","affiliation":[{"name":"6Cancer Physiology Project, National Cancer Center Research Institute East, Chiba, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Koyama","sequence":"additional","affiliation":[{"name":"2Pathophysiology of Renal Diseases, Medical Sciences for Control of Pathological Processes,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"4Graduate School of Comprehensive Human Sciences, Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Tsukuba, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyoshi","family":"Mori","sequence":"additional","affiliation":[{"name":"7Department of Pathology of Biological Response, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Takahashi","sequence":"additional","affiliation":[{"name":"1Department of Anatomy and Embryology, Biomolecular and Integrated Medical Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,1,19]]},"reference":[{"key":"2022061622153730100_B1","doi-asserted-by":"crossref","unstructured":"Nishizawa M, Kataoka K, Goto N, Fujiwara KT, Kawai S. v-maf, a viral oncogene that encodes a \u201cleucine zipper\u201d motif. Proc Natl Acad Sci U S A\u20081989; 86: 7711\u20135.","DOI":"10.1073\/pnas.86.20.7711"},{"key":"2022061622153730100_B2","doi-asserted-by":"crossref","unstructured":"Kataoka K, Noda M, Nishizawa M. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol Cell Biol\u20081994; 14: 700\u201312.","DOI":"10.1128\/mcb.14.1.700-712.1994"},{"key":"2022061622153730100_B3","doi-asserted-by":"crossref","unstructured":"Swaroop A, Xu J, Pawar H, Jackson A, Skolnick C, Agarwal N. A conserved retina-specific gene encodes a basic motif\/leucine zipper domain. Proc Natl Acad Sci U S A\u20081992; 89: 266\u201370.","DOI":"10.1073\/pnas.89.1.266"},{"key":"2022061622153730100_B4","doi-asserted-by":"crossref","unstructured":"Ogino H, Yasuda K. Induction of lens differentiation by activation of a bZIP transcription factor, L-Maf. Science\u20081998; 280: 115\u20138.","DOI":"10.1126\/science.280.5360.115"},{"key":"2022061622153730100_B5","doi-asserted-by":"crossref","unstructured":"Kajihara M, Kawauchi S, Kobayashi M, Ogino H, Takahashi S, Yasuda K. Isolation, characterization, and expression analysis of zebrafish large Mafs. J Biochem (Tokyo)\u20082001; 129: 139\u201346.","DOI":"10.1093\/oxfordjournals.jbchem.a002825"},{"key":"2022061622153730100_B6","doi-asserted-by":"crossref","unstructured":"Ho IC, Hodge MR, Rooney JW, Glimcher LH. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell\u20081996; 85: 973\u201383.","DOI":"10.1016\/S0092-8674(00)81299-4"},{"key":"2022061622153730100_B7","doi-asserted-by":"crossref","unstructured":"Kawauchi S, Takahashi S, Nakajima O, et al. Regulation of lens fiber cell differentiation by transcription factor c-Maf. J Biol Chem\u20081999; 274: 19254\u201360.","DOI":"10.1074\/jbc.274.27.19254"},{"key":"2022061622153730100_B8","doi-asserted-by":"crossref","unstructured":"Kim JI, Li T, Ho IC, Grusby MJ, Glimcher LH. Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. Proc Natl Acad Sci U S A\u20081999; 96: 3781\u20135.","DOI":"10.1073\/pnas.96.7.3781"},{"key":"2022061622153730100_B9","doi-asserted-by":"crossref","unstructured":"Ring BZ, Cordes SP, Overbeek PA, Barsh GS. Regulation of mouse lens fiber cell development and differentiation by the Maf gene. Development\u20082000; 127: 307\u201317.","DOI":"10.1242\/dev.127.2.307"},{"key":"2022061622153730100_B10","doi-asserted-by":"crossref","unstructured":"Chesi M, Bergsagel PL, Shonukan OO, et al. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood\u20081998; 91: 4457\u201363.","DOI":"10.1182\/blood.V91.12.4457"},{"key":"2022061622153730100_B11","doi-asserted-by":"crossref","unstructured":"Kuehl WM, Bergsagel PL. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer\u20082002; 2: 175\u201387.","DOI":"10.1038\/nrc746"},{"key":"2022061622153730100_B12","doi-asserted-by":"crossref","unstructured":"Seidl S, Kaufmann H, Drach J. New insights into the pathophysiology of multiple myeloma. Lancet Oncol\u20082003; 4: 557\u201364.","DOI":"10.1016\/S1470-2045(03)01195-1"},{"key":"2022061622153730100_B13","doi-asserted-by":"crossref","unstructured":"Hurt EM, Wiestner A, Rosenwald A, et al. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell\u20082004; 5: 191\u20139.","DOI":"10.1016\/S1535-6108(04)00019-4"},{"key":"2022061622153730100_B14","doi-asserted-by":"crossref","unstructured":"Kienast J, Berdel WE. c-maf in multiple myeloma: an oncogene enhancing tumor-stroma interactions. Cancer Cell\u20082004; 5: 109\u201310.","DOI":"10.1016\/S1535-6108(04)00030-3"},{"key":"2022061622153730100_B15","doi-asserted-by":"crossref","unstructured":"Zhumabekov T, Corbella P, Tolaini M, Kioussis D. Improved version of a human CD2 minigene based vector for T cell\u2013specific expression in transgenic mice. J Immunol Methods\u20081995; 185: 133\u201340.","DOI":"10.1016\/0022-1759(95)00124-S"},{"key":"2022061622153730100_B16","doi-asserted-by":"crossref","unstructured":"Rabbitts TH, Forster A, Larson R, Nathan P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet\u20081993; 4: 175\u201380.","DOI":"10.1038\/ng0693-175"},{"key":"2022061622153730100_B17","doi-asserted-by":"crossref","unstructured":"Shortman K, Wu L. Early T lymphocyte progenitors. Annu Rev Immunol\u20081996; 14: 29\u201347.","DOI":"10.1146\/annurev.immunol.14.1.29"},{"key":"2022061622153730100_B18","doi-asserted-by":"crossref","unstructured":"Palmiter RD, Brinster RL. Germ-line transformation of mice. Annu Rev Genet\u20081986; 20: 465\u201399.","DOI":"10.1146\/annurev.ge.20.120186.002341"},{"key":"2022061622153730100_B19","doi-asserted-by":"crossref","unstructured":"Lang G, Wotton D, Owen MJ, et al. The structure of the human CD2 gene and its expression in transgenic mice. EMBO J\u20081988; 7: 1675\u201382.","DOI":"10.1002\/j.1460-2075.1988.tb02995.x"},{"key":"2022061622153730100_B20","doi-asserted-by":"crossref","unstructured":"Kishihara K, Penninger J, Wallace VA, et al. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell\u20081993; 74: 143\u201356.","DOI":"10.1016\/0092-8674(93)90302-7"},{"key":"2022061622153730100_B21","doi-asserted-by":"crossref","unstructured":"Suzuki A, Iida S, Kato-Uranishi M, et al. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma. Oncogene\u20082005; 24: 6936\u201344.","DOI":"10.1038\/sj.onc.1208844"},{"key":"2022061622153730100_B22","doi-asserted-by":"crossref","unstructured":"Hardie DG, Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur J Biochem\u20081997; 246: 259\u201373.","DOI":"10.1111\/j.1432-1033.1997.00259.x"},{"key":"2022061622153730100_B23","doi-asserted-by":"crossref","unstructured":"Kemp BE, Mitchelhill KI, Stapleton D, et al. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci\u20081999; 24: 22\u20135.","DOI":"10.1016\/S0968-0004(98)01340-1"},{"key":"2022061622153730100_B24","doi-asserted-by":"crossref","unstructured":"Kemp BE, Stapleton D, Campbell DJ, et al. AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans\u20082003; 31: 162\u20138.","DOI":"10.1042\/bst0310162"},{"key":"2022061622153730100_B25","doi-asserted-by":"crossref","unstructured":"Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T, Esumi, H. ARK5 is a tumor invasion-associated factor downstream of Akt signaling. Mol Cell Biol\u20082004; 24: 3526\u201335.","DOI":"10.1128\/MCB.24.8.3526-3535.2004"},{"key":"2022061622153730100_B26","doi-asserted-by":"crossref","unstructured":"Kataoka K, Nishizawa M, Kawai S. Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family. J Virol\u20081993; 67: 2133\u201341.","DOI":"10.1128\/jvi.67.4.2133-2141.1993"},{"key":"2022061622153730100_B27","unstructured":"Larson RC, Fisch P, Larson TA, et al. T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. Oncogene\u20081994; 9: 3675\u201381."},{"key":"2022061622153730100_B28","doi-asserted-by":"crossref","unstructured":"Clark SS, Chen E, Fizzotti M, Witte ON, Malkovska V. BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets. J Virol\u20081993; 67: 6033\u201346.","DOI":"10.1128\/jvi.67.10.6033-6046.1993"},{"key":"2022061622153730100_B29","doi-asserted-by":"crossref","unstructured":"Xu Y, Sumter TF, Bhattacharya R, et al. The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. Cancer Res\u20082004; 64: 3371\u20135.","DOI":"10.1158\/0008-5472.CAN-04-0044"},{"key":"2022061622153730100_B30","doi-asserted-by":"crossref","unstructured":"Jimenez M, Perez de Castro I, Benet M, Garcia JF, Inghirami G, Pellicer A. The Rgr oncogene induces tumorigenesis in transgenic mice. Cancer Res\u20082004; 64: 6041\u20139.","DOI":"10.1158\/0008-5472.CAN-03-3389"},{"key":"2022061622153730100_B31","doi-asserted-by":"crossref","unstructured":"Anderson KC. Multiple Myeloma. Advances in disease biology: therapeutic implications. Semin Hematol\u20082001; 38: 6\u201310.","DOI":"10.1016\/S0037-1963(01)90088-5"},{"key":"2022061622153730100_B32","doi-asserted-by":"crossref","unstructured":"Shain KH, Landowski TH, Buyuksal I, Cantor AB, Dalton WS. Clonal variability in CD95 expression is the major determinant in Fas-medicated, but not chemotherapy-medicated apoptosis in the RPMI 8226 multiple myeloma cell line. Leukemia\u20082000; 14: 830\u201340.","DOI":"10.1038\/sj.leu.2401776"},{"key":"2022061622153730100_B33","doi-asserted-by":"crossref","unstructured":"Kusakai G, Suzuki A, Ogura T, et al. ARK5 expression in colorectal cancer and its implications for tumor progression. Am J Pathol\u20082004; 164: 987\u201395.","DOI":"10.1016\/S0002-9440(10)63186-0"},{"key":"2022061622153730100_B34","doi-asserted-by":"crossref","unstructured":"Zhao WL, Mourah S, Mounier N, et al. Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Lab Invest\u20082004; 84: 1512\u20139.","DOI":"10.1038\/labinvest.3700145"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/2\/812\/2556745\/812.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/2\/812\/2556745\/812.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T01:09:08Z","timestamp":1655428148000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/2\/812\/526500\/Overexpression-of-c-Maf-Contributes-to-T-Cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,15]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2006,1,19]]},"published-print":{"date-parts":[[2006,1,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-2154","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,15]]}}}